Press Releases

Baylor Genetics Launches Combination Test for COVID-19 and Influenza A and B

With the arrival of flu season, Baylor Genetics, a pioneer of genetic testing and precision medicine, has launched the latest combination test for the novel coronavirus, SARS-CoV-2, and Influenza A and B. “Baylor Genetics created the combination COVID-19 and flu test because the symptoms between the two are so similar, but the treatments are undeniably…

Baylor Genetics Launches Accessible, At-Home COVID-19 Test

Baylor Genetics, a clinical diagnostics laboratory known for genetic testing and precision medicine, announced its launch of an accessible and reliable at-home collection kit for COVID-19. With the launch of the at-home test, individuals nationwide will be able to order a test kit to determine if they are currently infected with COVID-19 within 48 hours…

Baylor Genetics and Rice University Form COVID-19 Screening Partnership for the Fall Semester

FOR IMMEDIATE RELEASE   Baylor Genetics and Rice University Form COVID-19 Screening Partnership for the Fall Semester; Partnership Aims for ‘Moon-Shot’ 48-Hours-or-Less Turnaround for Test Results   Houston, TX (August 13, 2020) – Baylor Genetics, a clinical diagnostics laboratory known for genetic testing and precision medicine, and Rice University, a private, comprehensive research university located in Houston, TX, have partnered together to create a first-of-its kind total turnkey solution for the university to resume…

Baylor Genetics and the City of Houston Form COVID-19 Testing Partnership

HOUSTON, TX (July 23, 2020) – In response to the global pandemic, Baylor Genetics, a pioneer in genetic testing and precision medicine, launched its official test for COVID-19 on June 16, 2020. To help prevent the spread of COVID-19 in Houston, Texas, Baylor Genetics has partnered with the Houston Health Department, City of Houston (COH),...

Baylor Genetics Launches Testing for COVID-19

Houston, TX (June 16, 2020) – In response to the global pandemic, Baylor Genetics, a pioneer of genetic testing and precision medicine, launched its official test for COVID-19. “For over 40 years, Baylor Genetics has focused on improving people’s lives by creating innovative tests. I can confidently state that innovation continues to be our focus,...

Baylor Genetics and King Faisal Specialist Hospital – Saudi Diagnostic Limited Sign Memorandum of Understanding (MOU)

FOR IMMEDIATE RELEASE Baylor Genetics and King Faisal Specialist Hospital – Saudi Diagnostic Limited Sign Memorandum of Understanding (MOU) to Build Strategic Partnership for All Genetic Testing and Precision Medicine HOUSTON, TEXAS / RIYADH, KINGDOM OF SAUDI ARABIA (May 10, 2019) – Houston-based Baylor Genetics (BG) and Riyadh-based Saudi Diagnostic Limited (SDL), a subsidiary of…

Baylor Genetics Launches Whole Genome Sequencing

FOR IMMEDIATE RELEASE Baylor Genetics Launches Clinical Whole Genome Sequencing HOUSTON, TX (Feb. 4, 2019) – Baylor Genetics, a leader in genetic testing, announced today the launch of clinical whole genome sequencing (WGS) for the diagnosis of rare genetic and inherited disorders.   “For the past two decades, Baylor Genetics has been pioneering the field…

Baylor Genetics expands its precision medicine portfolio with ClariFind, a somatic tumor test using next-generation sequencing to match genomic results with personalized treatment options.

Note: ClariFind has been discontinued at Baylor Genetics. Houston, TX – March 6, 2018 – Baylor Genetics announces today the launch of ClariFind, a comprehensive somatic tumor next-generation sequencing test that correlates genomic results with specific drug therapies and clinical trial options. Baylor Genetics’ experts, in collaboration with Baylor College of Medicine, developed ClariFind to…

Genetic Counselors Can Help You Navigate The Murky Waters Of Genetic Testing

CHICAGO – Nov. 9, 2017 – Social and regular media are filled with information about all the genetic tests available and the latest genes discovered by researchers. You can’t help but wonder whether you should be tested and what the results might mean. So where do you turn? Genetic counselors are the professionals who can…

Baylor Genetics Partners with Rainbow Genomics Offering Adult Wellness Screening and High-Risk Cancer Exome Sequencing Tests in Asian Pacific

Hong Kong / Houston, Texas – Baylor Genetics announces a partnership with Hong Kong-based Rainbow Genomics to provide clinical whole exome sequencing tests to patients in Hong Kong, Japan, Singapore and other Asian countries. Product offering includes adult exome screening, high-risk cancer and wellness cancer tests. Unlike many “recreational” consumer genetic tests currently available in…

Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System

South San Francisco, California / Houston, Texas – Fluidigm Corporation (NASDAQ:FLDM) and Baylor Genetics today announced that they have entered into a licensing agreement to offer a next-generation sequencing (NGS) library prep assay that enables efficient sequencing of the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Under the agreement, Fluidigm obtains the rights to commercialize…

Baylor Genetics Selects Edico Genome’s DRAGEN To Improve Turnaround Times

San Diego, California / Houston, Texas – Baylor Genetics Selects Edico Genome’s DRAGEN to Improve Turnaround Times for Clinical Tests, Enabling Physicians and Genetic Counselors to be ‘Ready with Answers’ Faster Than Ever. Baylor Genetics, a genetics laboratory specializing in the development and commercialization of the highest quality genetic testing and genomic lab testing, today…

Baylor Genetics Selects Edico Genome's DRAGEN To Improve Turnaround Times

San Diego, California / Houston, Texas – Baylor Genetics Selects Edico Genome’s DRAGEN to Improve Turnaround Times for Clinical Tests, Enabling Physicians and Genetic Counselors to be ‘Ready with Answers’ Faster Than Ever. Baylor Genetics, a genetics laboratory specializing in the development and commercialization of the highest quality genetic testing and genomic lab testing, today…

Baylor Genetics Announces Strategic Partnership With Diversigen

Houston, Texas – Baylor Miraca today announced a strategic partnership with Diversigen, Inc., the leading provider of comprehensive microbiome analysis services, to provide its customers access to a broad range of targeted genomics and metabolomics services. The two companies, both commercial endeavors of Baylor College of Medicine, are leveraging the scientific acumen and research infrastructure…

Baylor Genetics Incorporates Oxford Gene Technology’s SNP Array Probe Technology

Houston, Texas – Baylor Genetics has entered into an agreement with Oxford Gene Technology (OGT), The Molecular Genetics Company, to license the use of OGT’s proprietary single nucleotide polymorphism (SNP) array probe technology. As part of the agreement, Baylor Genetics will utilize aCGH arrays containing both copy number variation (CNV) and SNP probes to identify…

Critical WES Launches Enhanced Clinical Exome Sequencing Test, Faster Delivery of Results

Houston, Texas – Baylor Genetics announced today the launch of an enhanced clinical exome sequencing test, a new option for physicians that speeds up delivery of final results to two-three weeks from three months. The test, called CriticalWES trio, brings industry best turnaround time to a test already known for its superior coverage and content….

Menu